Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1345

1.

Association of Blood Pressure Patterns in Young Adulthood With Cardiovascular Disease and Mortality in Middle Age.

Yano Y, Reis JP, Lewis CE, Sidney S, Pletcher MJ, Bibbins-Domingo K, Navar AM, Peterson ED, Bancks MP, Kanegae H, Gidding SS, Muntner P, Lloyd-Jones DM.

JAMA Cardiol. 2020 Jan 22. doi: 10.1001/jamacardio.2019.5682. [Epub ahead of print]

PMID:
31968050
2.

Incidence, Temporal Trends, and Associated Outcomes of Vascular and Bleeding Complications in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry.

Sherwood MW, Xiang K, Matsouaka R, Li Z, Vemulapalli S, Vora AN, Fanaroff A, Harrison JK, Thourani VH, Holmes D, Kirtane A, Pineda AM, Peterson ED, Rao SV.

Circ Cardiovasc Interv. 2020 Jan;13(1):e008227. doi: 10.1161/CIRCINTERVENTIONS.119.008227. Epub 2020 Jan 15.

PMID:
31937138
3.

Have the Major Cardiovascular Outcomes Trials Impacted Payer Approval Rates for PCSK9 Inhibitors?

Navar AM, Mulder HM, Wojdyla DM, Peterson ED.

Circ Cardiovasc Qual Outcomes. 2020 Jan;13(1):e006019. doi: 10.1161/CIRCOUTCOMES.119.006019. Epub 2020 Jan 10. No abstract available.

PMID:
31918581
4.

Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation.

Inohara T, Holmes DN, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Hylek EM, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP; ORBIT AF Patients and Investigators.

Heart. 2020 Jan 7. pii: heartjnl-2019-315792. doi: 10.1136/heartjnl-2019-315792. [Epub ahead of print]

PMID:
31911503
5.

In-Hospital Cardiac Arrest Resuscitation Practices and Outcomes in Maintenance Dialysis Patients.

Starks MA, Wu J, Peterson ED, Stafford JA, Matsouaka RA, Boulware LE, Svetkey LP, Chan PS, Pun PH; for American Heart Association’s Get With the Guidelines-Resuscitation Investigators.

Clin J Am Soc Nephrol. 2020 Jan 7. pii: CJN.05070419. doi: 10.2215/CJN.05070419. [Epub ahead of print]

PMID:
31911423
6.

Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months: Findings From Get With The Guidelines-Stroke.

Shah S, Liang L, Kosinski A, Hernandez AF, Schwamm LH, Smith EE, Fonarow GC, Bhatt DL, Feng W, Peterson ED, Xian Y.

Circ Cardiovasc Qual Outcomes. 2020 Jan;13(1):e006031. doi: 10.1161/CIRCOUTCOMES.119.006031. Epub 2020 Jan 6.

PMID:
31903770
7.

Translating the Secondary Prevention Therapeutic Boom Into Action.

Nanna MG, Peterson ED.

JAMA Cardiol. 2020 Jan 2. doi: 10.1001/jamacardio.2019.4959. [Epub ahead of print] No abstract available.

PMID:
31895445
8.

Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation.

Freeman JV, Shrader P, Pieper KS, Allen LA, Chan PS, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel JA, Singer DE, Go AS, Hylek EM, Steinberg BA, Peterson ED, Piccini JP.

Circ Arrhythm Electrophysiol. 2019 Dec;12(12):e007612. doi: 10.1161/CIRCEP.119.007612. Epub 2019 Dec 13.

PMID:
31830822
9.

Rhythm Control Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: Insights From Get With The Guidelines-Heart Failure.

Kelly JP, DeVore AD, Wu J, Hammill BG, Sharma A, Cooper LB, Felker GM, Piccini JP, Allen LA, Heidenreich PA, Peterson ED, Yancy CW, Fonarow GC, Hernandez AF.

J Am Heart Assoc. 2019 Dec 17;8(24):e011560. doi: 10.1161/JAHA.118.011560. Epub 2019 Dec 10.

10.

Patterns of amiodarone use and outcomes in clinical practice for atrial fibrillation.

Pokorney SD, Holmes DN, Shrader P, Thomas L, Fonarow GC, Mahaffey KW, Gersh BJ, Kowey PR, Naccarelli GV, Freeman JV, Singer DE, Washam JB, Peterson ED, Piccini JP, Reiffel JA.

Am Heart J. 2019 Oct 23;220:145-154. doi: 10.1016/j.ahj.2019.09.017. [Epub ahead of print]

PMID:
31812756
11.

Low-density lipoprotein cholesterol treatment and outcomes in patients with type 2 diabetes and established cardiovascular disease: Insights from TECOS.

De Ferrari GM, Stevens SR, Ambrosio G, Leonardi S, Armstrong PW, Green JB, Wamil M, Holman RR, Peterson ED; TECOS Study Group.

Am Heart J. 2019 Nov 13;220:82-88. doi: 10.1016/j.ahj.2019.11.005. [Epub ahead of print]

PMID:
31790905
12.

Videos to reduce racial disparities in ICD therapy Via Innovative Designs (VIVID) trial: Rational, design and methodology.

Thomas KL, Sullivan LT 2nd, Al-Khatib SM, LaPointe NA, Sears S, Kosinski AS, Jackson LR 2nd, Kutyifa V, Peterson ED.

Am Heart J. 2019 Nov 11;220:59-67. doi: 10.1016/j.ahj.2019.10.011. [Epub ahead of print]

PMID:
31785550
13.

Machine Learning, Predictive Analytics, and Clinical Practice: Can the Past Inform the Present?

Peterson ED.

JAMA. 2019 Nov 22. doi: 10.1001/jama.2019.17831. [Epub ahead of print] No abstract available.

PMID:
31755902
14.

Effects of Virtual Exercise Rehabilitation In-Home Therapy Compared with Traditional Care After Total Knee Arthroplasty: VERITAS, a Randomized Controlled Trial.

Prvu Bettger J, Green CL, Holmes DN, Chokshi A, Mather RC 3rd, Hoch BT, de Leon AJ, Aluisio F, Seyler TM, Del Gaizo DJ, Chiavetta J, Webb L, Miller V, Smith JM, Peterson ED.

J Bone Joint Surg Am. 2020 Jan 15;102(2):101-109. doi: 10.2106/JBJS.19.00695.

PMID:
31743238
15.

Age, knowledge, preferences, and risk tolerance for invasive cardiac care.

Nanna MG, Peterson ED, Wu A, Harding T, Galanos AN, Wruck L, Alexander KP.

Am Heart J. 2020 Jan;219:99-108. doi: 10.1016/j.ahj.2019.09.008. Epub 2019 Oct 23.

PMID:
31733450
16.

Claims-based cardiovascular outcome identification for clinical research: Results from 7 large randomized cardiovascular clinical trials.

Brennan JM, Wruck L, Pencina MJ, Clare RM, Lopes RD, Alexander JH, O'Brien S, Krucoff M, Rao SV, Wang TY, Curtis LH, Newby LK, Granger CB, Patel M, Mahaffey K, Ross JS, Normand SL, Eloff BC, Caños DA, Lokhnygina YV, Roe MT, Califf RM, Marinac-Dabic D, Peterson ED.

Am Heart J. 2019 Dec;218:110-122. doi: 10.1016/j.ahj.2019.09.002. Epub 2019 Sep 12.

PMID:
31726314
17.

Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial.

Fanaroff AC, Peterson ED, Kaltenbach LA, Cannon CP, Choudhry NK, Henry TD, Anstrom KJ, Cohen DJ, Fonseca E, Khan ND, Fonarow GC, Wang TY.

JAMA Cardiol. 2019 Nov 13. doi: 10.1001/jamacardio.2019.4408. [Epub ahead of print]

PMID:
31721978
18.

Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease.

Shavadia JS, Zheng Y, Green JB, Armstrong PW, Westerhout CM, McGuire DK, Cornel JH, Holman RR, Peterson ED.

Am Heart J. 2019 Dec;218:92-99. doi: 10.1016/j.ahj.2019.09.013. Epub 2019 Oct 20.

PMID:
31715435
19.

Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease.

Welsh RC, Peterson ED, De Caterina R, Bode C, Gersh B, Eikelboom JW.

Am Heart J. 2019 Dec;218:100-109. doi: 10.1016/j.ahj.2019.09.006. Epub 2019 Oct 23. Review.

PMID:
31715433
20.

A systematic review of randomized trials comparing double versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.

Sullivan AE, Nanna MG, Rao SV, Cantrell S, Gibson CM, Verheugt FWA, Peterson ED, Lopes RD, Alexander JH, Granger CB, Yee MK, Kong DF.

Catheter Cardiovasc Interv. 2019 Nov 11. doi: 10.1002/ccd.28535. [Epub ahead of print]

PMID:
31713326
21.

Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation.

Loring Z, Shrader P, Allen LA, Blanco R, Chan PS, Ezekowitz MD, Fonarow GC, Freeman JV, Gersh BJ, Mahaffey KW, Naccarelli GV, Pieper K, Reiffel JA, Singer DE, Steinberg BA, Thomas LE, Peterson ED, Piccini JP.

Am Heart J. 2020 Jan;219:21-30. doi: 10.1016/j.ahj.2019.10.008. Epub 2019 Nov 8.

PMID:
31710841
22.

Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI Trial.

Kerneis M, Yee MK, Mehran R, Nafee T, Bode C, Halperin JL, Peterson ED, Verheugt FWA, Wildgoose P, van Eickels M, Lip GYH, Cohen M, Fox KAA, Gibson CM.

Circ Cardiovasc Interv. 2019 Nov;12(11):e008160. doi: 10.1161/CIRCINTERVENTIONS.119.008160. Epub 2019 Nov 11.

PMID:
31707805
23.

International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS.

Bhatt AS, Luo N, Solomon N, Pagidipati NJ, Ambrosio G, Green JB, McGuire DK, Standl E, Cornel JH, Halvorsen S, Lopes RD, White HD, Holman RR, Peterson ED, Mentz RJ; TECOS Study Group.

Am Heart J. 2019 Dec;218:57-65. doi: 10.1016/j.ahj.2019.08.016. Epub 2019 Aug 28.

PMID:
31707329
24.

Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS.

Pagidipati NJ, Zheng Y, Green JB, McGuire DK, Mentz RJ, Shah S, Aschner P, Delibasi T, Rodbard HW, Westerhout CM, Holman RR, Peterson ED; TECOS Study Group.

Am Heart J. 2020 Jan;219:47-57. doi: 10.1016/j.ahj.2019.09.016. Epub 2019 Oct 20.

PMID:
31707324
25.

The Accuracy of Cardiovascular Pooled Cohort Risk Estimates in U.S. Older Adults.

Nanna MG, Peterson ED, Wojdyla D, Navar AM.

J Gen Intern Med. 2019 Oct 30. doi: 10.1007/s11606-019-05361-4. [Epub ahead of print]

PMID:
31667745
26.

Technology-Enabled Clinical Trials: Transforming Medical Evidence Generation.

Marquis-Gravel G, Roe MT, Turakhia MP, Boden W, Temple R, Sharma A, Hirshberg B, Slater P, Craft N, Stockbridge N, McDowell B, Waldstreicher J, Bourla A, Bansilal S, Wong JL, Meunier C, Kassahun H, Coran P, Bataille L, Patrick-Lake B, Hirsch B, Reites J, Mehta R, Muse ED, Chandross KJ, Silverstein JC, Silcox C, Overhage JM, Califf RM, Peterson ED.

Circulation. 2019 Oct 22;140(17):1426-1436. doi: 10.1161/CIRCULATIONAHA.119.040798. Epub 2019 Oct 21.

PMID:
31634011
27.

Racial Differences in Elevated C-Reactive Protein Among US Older Adults.

Farmer HR, Wray LA, Xian Y, Xu H, Pagidipati N, Peterson ED, Dupre ME.

J Am Geriatr Soc. 2019 Oct 21. doi: 10.1111/jgs.16187. [Epub ahead of print]

PMID:
31633808
28.

Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF.

Greene SJ, DeVore AD, Sheng S, Fonarow GC, Butler J, Califf RM, Hernandez AF, Matsouaka RA, Samman Tahhan A, Thomas KL, Vaduganathan M, Yancy CW, Peterson ED, O'Connor CM, Mentz RJ.

JACC Heart Fail. 2019 Nov;7(11):980-992. doi: 10.1016/j.jchf.2019.07.011. Epub 2019 Oct 9.

PMID:
31606362
29.

Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry.

Xian Y, Navar AM, Li S, Li Z, Robinson J, Virani SS, Louie MJ, Koren A, Goldberg A, Roger VL, Wilson PWF, Peterson ED, Wang TY.

J Am Heart Assoc. 2019 Oct;8(19):e013229. doi: 10.1161/JAHA.119.013229. Epub 2019 Sep 26.

30.

Readmissions After Acute Myocardial Infarction: How Often Do Patients Return to the Discharging Hospital?

Rymer JA, Chen AY, Thomas L, Fonarow GC, Peterson ED, Wang TY.

J Am Heart Assoc. 2019 Oct;8(19):e012059. doi: 10.1161/JAHA.119.012059. Epub 2019 Sep 20.

31.

Rivaroxaban versus warfarin treatment among morbidly obese patients with venous thromboembolism: Comparative effectiveness, safety, and costs.

Spyropoulos AC, Ashton V, Chen YW, Wu B, Peterson ED.

Thromb Res. 2019 Oct;182:159-166. doi: 10.1016/j.thromres.2019.08.021. Epub 2019 Aug 22.

32.

Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOS.

Nauck MA, McGuire DK, Pieper KS, Lokhnygina Y, Strandberg TE, Riefflin A, Delibasi T, Peterson ED, White HD, Scott R, Holman RR.

Cardiovasc Diabetol. 2019 Sep 3;18(1):116. doi: 10.1186/s12933-019-0921-2.

33.

Direct oral anticoagulant- versus vitamin K antagonist-related gastrointestinal bleeding: Insights from a nationwide cohort.

Butt JH, Li A, Xian Y, Peterson ED, Garcia D, Torp-Pedersen C, Køber L, Fosbøl EL.

Am Heart J. 2019 Oct;216:117-124. doi: 10.1016/j.ahj.2019.07.012. Epub 2019 Jul 25.

PMID:
31425898
34.

Sex Differences in the Use of Statins in Community Practice.

Nanna MG, Wang TY, Xiang Q, Goldberg AC, Robinson JG, Roger VL, Virani SS, Wilson PWF, Louie MJ, Koren A, Li Z, Peterson ED, Navar AM.

Circ Cardiovasc Qual Outcomes. 2019 Aug;12(8):e005562. doi: 10.1161/CIRCOUTCOMES.118.005562. Epub 2019 Aug 16.

PMID:
31416347
35.

Intravenous Tissue Plasminogen Activator in Stroke Mimics.

Ali-Ahmed F, Federspiel JJ, Liang L, Xu H, Sevilis T, Hernandez AF, Kosinski AS, Prvu Bettger J, Smith EE, Bhatt DL, Schwamm LH, Fonarow GC, Peterson ED, Xian Y.

Circ Cardiovasc Qual Outcomes. 2019 Aug;12(8):e005609. doi: 10.1161/CIRCOUTCOMES.119.005609. Epub 2019 Aug 15.

PMID:
31412730
36.

The Association Between Low-Density Lipoprotein Cholesterol and Incident Atherosclerotic Cardiovascular Disease in Older Adults: Results From the National Institutes of Health Pooled Cohorts.

Nanna MG, Navar AM, Wojdyla D, Peterson ED.

J Am Geriatr Soc. 2019 Dec;67(12):2560-2567. doi: 10.1111/jgs.16123. Epub 2019 Aug 14.

PMID:
31411740
37.

The patient journey with proprotein convertase subtilisin/kexin type 9 inhibitors in community practice.

Bradley CK, Shrader P, Sanchez RJ, Peterson ED, Navar AM.

J Clin Lipidol. 2019 Sep - Oct;13(5):725-734. doi: 10.1016/j.jacl.2019.06.008. Epub 2019 Jul 2.

38.

Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke: Findings From the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study.

Xian Y, Xu H, O'Brien EC, Shah S, Thomas L, Pencina MJ, Fonarow GC, Olson DM, Schwamm LH, Bhatt DL, Smith EE, Hannah D, Maisch L, Lytle BL, Peterson ED, Hernandez AF.

JAMA Neurol. 2019 Jul 22. doi: 10.1001/jamaneurol.2019.2099. [Epub ahead of print]

PMID:
31329212
39.

Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy.

Inohara T, Liang L, Kosinski AS, Smith EE, Schwamm LH, Hernandez AF, Bhatt DL, Fonarow GC, Peterson ED, Xian Y.

J Am Heart Assoc. 2019 Aug 6;8(15):e012450. doi: 10.1161/JAHA.119.012450. Epub 2019 Jul 20.

40.

Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice.

Jahan R, Saver JL, Schwamm LH, Fonarow GC, Liang L, Matsouaka RA, Xian Y, Holmes DN, Peterson ED, Yavagal D, Smith EE.

JAMA. 2019 Jul 16;322(3):252-263. doi: 10.1001/jama.2019.8286.

41.

Atherosclerotic cardiovascular disease and heart failure: Determinants of risk and outcomes in patients with diabetes.

Nelson AJ, Peterson ED, Pagidipati NJ.

Prog Cardiovasc Dis. 2019 Jul - Aug;62(4):306-314. doi: 10.1016/j.pcad.2019.07.001. Epub 2019 Jul 10. Review.

PMID:
31301314
42.

Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly Patients.

Shavadia JS, Holmes DN, Thomas L, Peterson ED, Granger CB, Roe MT, Wang TY.

Circ Cardiovasc Qual Outcomes. 2019 Jul;12(7):e005103. doi: 10.1161/CIRCOUTCOMES.118.005103. Epub 2019 Jul 9.

PMID:
31284739
43.

Trajectories of Non-HDL Cholesterol Across Midlife: Implications for Cardiovascular Prevention.

Pencina KM, Thanassoulis G, Wilkins JT, Vasan RS, Navar AM, Peterson ED, Pencina MJ, Sniderman AD.

J Am Coll Cardiol. 2019 Jul 9;74(1):70-79. doi: 10.1016/j.jacc.2019.04.047.

PMID:
31272554
44.

Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.

Pokorney SD, Holmes DN, Thomas L, Fonarow GC, Kowey PR, Reiffel JA, Singer DE, Freeman JV, Gersh BJ, Mahaffey KW, Hylek EM, Naccarelli GV, Ezekowitz MD, Piccini JP, Peterson ED; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators.

JAMA Cardiol. 2019 Jul 3. doi: 10.1001/jamacardio.2019.1960. [Epub ahead of print]

45.

Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry.

Nanna MG, Navar AM, Wang TY, Li S, Virani SS, Li Z, Robinson JG, Roger VL, Wilson PWF, Goldberg AC, Koren A, Louie MJ, Peterson ED.

Am Heart J. 2019 Aug;214:113-124. doi: 10.1016/j.ahj.2019.05.009. Epub 2019 May 22.

PMID:
31202098
46.

Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II.

Inohara T, Shrader P, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Go AS, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP; ORBIT AF Patients and Investigators.

Am Heart J. 2019 Jul;213:81-90. doi: 10.1016/j.ahj.2019.04.007. Epub 2019 Apr 24.

PMID:
31129441
47.

Thrombolysis in young adults with stroke: Findings from Get With The Guidelines-Stroke.

Dodds JA, Xian Y, Sheng S, Fonarow GC, Bhatt DL, Matsouaka R, Schwamm LH, Peterson ED, Smith EE.

Neurology. 2019 Jun 11;92(24):e2784-e2792. doi: 10.1212/WNL.0000000000007653. Epub 2019 May 15.

PMID:
31092622
48.

Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life Score.

Holmes DN, Piccini JP, Allen LA, Fonarow GC, Gersh BJ, Kowey PR, O'Brien EC, Reiffel JA, Naccarelli GV, Ezekowitz MD, Chan PS, Singer DE, Spertus JA, Peterson ED, Thomas L.

Circ Cardiovasc Qual Outcomes. 2019 May;12(5):e005358. doi: 10.1161/CIRCOUTCOMES.118.005358.

PMID:
31092022
49.

Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes.

Guimarães PO, Peterson ED, Stevens SR, Lokhnygina Y, Green JB, McGuire DK, Holman RR, Lopes RD.

Int J Cardiol. 2019 Aug 15;289:58-62. doi: 10.1016/j.ijcard.2019.04.085. Epub 2019 Apr 30.

PMID:
31079973
50.

Safety of Dual-Antiplatelet Therapy After Myocardial Infarction Among Patients With Chronic Kidney Disease.

Rymer JA, Kaltenbach LA, Doll JA, Messenger JC, Peterson ED, Wang TY.

J Am Heart Assoc. 2019 May 21;8(10):e012236. doi: 10.1161/JAHA.119.012236.

Supplemental Content

Loading ...
Support Center